Alex Denner (Getty Images)

A sec­ond Carl Ic­ahn pro­tégé jumps in on SPAC spree, as Alex Den­ner guns for $175M

A sec­ond Carl Ic­ahn pro­tégé is jump­ing in­to the biotech SPAC rush, this time one with a lot more ex­pe­ri­ence — and a lot more of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.